FDA approves AZ's anifrolumab, ending 10-year lupus drug dro...

AstraZeneca has completed the resurrection of its anifrolumab drug for systemic lupus erythematosus (SLE) after claiming FDA approval for the drug as an add-on therapy for adults with the a